Recordati reports first half results with sales up 6.3%

Italian drugmaker Recordati (RC: MI) saw its shares rise 2.1% to 12.30 euros after the companyreleased first half financial results showing that sales are up 6.3%.

The firm’s consolidated revenue in the first half of 2014 was 507.6 million euros ($681 million), up by 6.3% compared to the same period last year, when revenue was 477.7 million euros. International sales grew by 8.6% from 354 million euros to 328 million euros.

The company’s earnings before interest, taxes, depreciation and amortization (EBITDA), at 27.9% of sales, were 141.9 million euros, an increase of 18.2% over the same period of the preceding year.